Carcinoma: all 6,718 studies

Page 45 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• CTC Detection Rate in SCCHN With a in Vivo DeviceStatus unknownNCT03071900Not applicable
• INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersCompletedNCT03071328Early Phase 1
• A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial CarcinomaCompletedNCT03070990Phase 1
• Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)WithdrawnNCT03070691Phase 2/3
• Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-ScopeStatus unknownNCT03069846Not applicable
• Clemizole HCl for Subjects With Hepatocellular CarcinomaStatus unknownNCT03069508Phase 2
• IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal CarcinomaStatus unknownNCT03068936Phase 3
• Study of the Combination of TACE With Apatinib in Patients With Hepatocellular CarcinomaStatus unknownNCT03066557Not applicable
• Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.CompletedNCT03066427Phase 2
• The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryCompletedNCT03064308Not applicable
• Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)CompletedNCT03063762Phase 1
• Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell CarcinomaStatus unknownNCT03062410Not applicable
• The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical RecurrenceStatus unknownNCT03062059Phase 2
• Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03058432Phase 2
• Immune Response Evaluation to Curative Conventional TherapyStatus unknownNCT03053661
• LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry)CompletedNCT03053596
• Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)TerminatedNCT03053297
• Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial TractCompletedNCT03051373Phase 2
• Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal CancerTerminatedNCT03049358Not applicable
• HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/BCompletedNCT03048123Phase 2
• Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCCCompletedNCT03047603
• Study of DC-CTL Combined With CIK for Advanced Solid TumorStatus unknownNCT03047525Phase 1/2
• Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03047265Phase 2
• Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)Status unknownNCT03046979Phase 2
• Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by ChemoradiotherapyStatus unknownNCT03045484Not applicable
• PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated MalignanciesStatus unknownNCT03044743Phase 1/2
• Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLCCompletedNCT03044626Phase 2
• Immunological Response After Ablative Therapy in the LiverWithdrawnNCT03040453Not applicable
• Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell CarcinomaWithdrawnNCT03035630Phase 2
• Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell CarcinomaCompletedNCT03035188Phase 2
• Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisTerminatedNCT03035006Phase 1/2
• Thrombin Generation and Platelet Activation in CRS/HIPECCompletedNCT03034850
• WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck CancerCompletedNCT03028766Phase 1
• Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' TreatmentStatus unknownNCT03028155Phase 3
• A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerCompletedNCT03027284Phase 1
• Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT03025958Phase 2
• Prospective Study for Prognostic Biomarkers of Nasopharyngeal CarcinomaStatus unknownNCT03025854
• Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in SituStatus unknownNCT03025724Not applicable
• Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative TreatmentActive, not recruitingNCT03024684Phase 4
• Pulmonary sarcomatoid_MEDI4736+TremeCompletedNCT03022500Phase 2
• A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).CompletedNCT03022409Phase 1
• HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCCStatus unknownNCT03020342
• Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03020329Phase 2
• Alpha Radiation Emitters Device for the Treatment of Squamous Cell CarcinomaCompletedNCT03015883Not applicable
• Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal CarcinomaStatus unknownNCT03015727Phase 3
• Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line TherapyTerminatedNCT03013946Phase 3
• CLE Characteristics of Upper Urinary Tract Urothelial CarcinomaCompletedNCT03013920
• A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerStatus unknownNCT03013712Phase 1/2
• Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic RegimenCompletedNCT03013335Phase 2
• Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor ThrombosisCompletedNCT03009461Phase 2
• A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibTerminatedNCT03008512Phase 2
• Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein ThrombosisCompletedNCT03007212Phase 4
• EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) PatientsStatus unknownNCT03006588Phase 2/3
• PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMACompletedNCT03006432Phase 3
• Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma PatientsStatus unknownNCT03005756Not applicable
• Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the BreastCompletedNCT03002766Phase 2
• Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCCCompletedNCT03001596Not applicable
• A Study of SBRT for OligoMetastatic ESCCCompletedNCT03000816Not applicable
• Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCCCompletedNCT02999646Not applicable
• Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)WithdrawnNCT02997956Phase 1/2
• Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02993991Phase 1
• Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in EgyptCompletedNCT02990351
• Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaWithdrawnNCT02989870Phase 1
• Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular PatientsCompletedNCT02988440Phase 1
• The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.Status unknownNCT02987907Phase 3
• SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical CarcinomaCompletedNCT02986867Not applicable
• Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral TongueStatus unknownNCT02985255Phase 2
• Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
• Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast CancerCompletedNCT02983279Not applicable
• Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular CarcinomaCompletedNCT02981498Phase 2
• Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)Active, not recruitingNCT02978118
• Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell CarcinomaCompletedNCT02976909Phase 2
• Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard TreatmentCompletedNCT02976896Phase 2
• Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT02969473Phase 2
• Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCCStatus unknownNCT02967887Phase 2
• Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT02964455Phase 1
• RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular CarcinomaStatus unknownNCT02964260Not applicable
• Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)WithdrawnNCT02962804Phase 2
• Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease ControlTerminatedNCT02959554Phase 2
• Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02958111Phase 3
• To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell CarcinomaTerminatedNCT02956889Phase 2
• Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT02956772Phase 2
• Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT02953743Phase 1
• A Safety Study of SGN-2FF for Patients With Advanced Solid TumorsTerminatedNCT02952989Phase 1
• Bladder Cancer Adjuvant Radiotherapy TrialActive, not recruitingNCT02951325Phase 3
• A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma PatientsStatus unknownNCT02948699Phase 4
• PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerWithdrawnNCT02948101Phase 2
• Investigation of the Role of the Microbiome in the Pathogenesis of Colorectal Adenoma and CarcinomaCompletedNCT02947607
• HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell CarcinomaTerminatedNCT02947152Phase 1
• Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular CarcinomaWithdrawnNCT02946138Phase 2
• Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02944708Phase 3
• Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing SurgeryWithdrawnNCT02944357Not applicable
• Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine CarcinomaStatus unknownNCT02943798Phase 2
• Quantitative Optical Sensor Findings in Head & Neck Squamous Cell CarcinomaStatus unknownNCT02943044
• Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic CarcinomaStatus unknownNCT02942693Phase 2
• Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric CancerStatus unknownNCT02942329Phase 1/2
• Factors Influencing the 3-Year Recurrence of Liver Carcinoma After SurgeryCompletedNCT02941861
• TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal CarcinomaCompletedNCT02940925Phase 3
• A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT02939807Phase 2
• Study of Electronic Brachytherapy for Cutaneous Basal Cell CarcinomaCompletedNCT02939027Not applicable

← Carcinoma overview